COVID-19 Vaccine Related Hyperosmolar Hyperglycemic State and Normalized Glycemia within 2 Months

To protect from COVID-19 pandemic, several vaccines were developed infection with expected immunity against a SARS-CoV-2 infection. Short time side effects are reported. New onset diabetes was reported after Here we report case of new presenting hyperosmolar hyperglycemic state, whose symptoms followed right the second dose Pfizer-BioNTech Vaccine. He is 56-year old, obese Afro-American Veteran no family history and HbA1C 5.6 forty-five days prior to hospitalization. noted polyurea excessive thirst following vaccine. Hospitalized state more than 14, he treated initially insulin drip changed basal, bolus regimen. In addition, had oral thrush, requiring antifungal therapy. needed higher doses during hospitalization at discharge. rapidly recovered could be tapered off in 4 months normal glycemic state. We conclude that this present first rapid recovery